Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients.

Population Impact of Using the PREVENT Equations to Guide the Management of Stage 1 Hypertension in the United States.

Earlier versus delayed ruxolitinib treatment for patients with myelofibrosis: a plain language summary.

Distress and Care Utilization in Patients with Myeloproliferative Neoplasms.

Length of Time in the United States and Cardiometabolic Outcomes Among Foreign and US-Born Black Adults.

Polycythemia vera: past, present and future.

Improving Collection and Analysis of Overall Survival Data.

Safety and efficacy of fedratinib in patients with myelofibrosis previously treated with ruxolitinib: primary analysis of FREEDOM trial.

Inhibition of miRNA associated with a disease-specific signature and secreted via extracellular vesicles of systemic lupus erythematosus patients suppresses target organ inflammation in a humanized mouse model.

Association Between Hypertensive Disorders of Pregnancy and Interval Neurocognitive Decline: An Analysis of the Hispanic Community Health Study/Study of Latinos.